Showing results (1511-1520 of 4,063) with videos related to

Sort By:
Pageof 407
Endocrine Journal|September 20, 2006
Intracellular calcium and sodium-lithium countertransport in type 2 diabetic patients with and without albuminuriaHenry Völzke, Sybille Gruska, Dirk Vogelgesang, et al.
Endocrine Journal|September 27, 2006
Growth hormone (GH) effects on central fat accumulation in adult Japanese GH deficient patients: 6-month fixed-dose effects persist during second 6-month individualized-dose phaseKazuo Chihara, Akira Shimatsu, Yuzuru Kato, et al.
Endocrine Journal|September 27, 2006
Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytesKazuhiko Muraki, Shigeru Okuya, Yukio Tanizawa
Endocrine Journal|July 20, 2006
Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytesMikiko Asai-Sato, Machi Okamoto, Masaya Endo, et al.
Endocrine Journal|July 20, 2006
Ganglionic adrenergic action modulates ovarian steroids and nitric oxide in prepubertal ratSilvia Marcela Delgado, Marilina Casais, Zulema Sosa, et al.
Endocrine Journal|November 25, 2006
Activation of c-Jun NH2-terminal kinase during islet isolationHirofumi Noguchi
Endocrine Journal|October 21, 2006
The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' diseaseKumiko Tsuboi, Hajime Ueshiba, Masako Shimojo, et al.
Endocrine Journal|October 21, 2006
Insulin responses to selective arterial calcium infusion under hyperinsulinemic euglycemic glucose clamps: case studies in adult nesidioblastosis and childhood insulinomaAtsushi Nakagawa, Keiichi Ueno, Masatsune Ito, et al.
Endocrine Journal|November 9, 2006
Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacementBaris Akinci, Abdurrahman Comlekci, Mehmet Ali Ozcan, et al.
Endocrine Journal|September 20, 2006
Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' diseaseTakashi Yamada, Ichiro Komiya, Yasuhiro Miyahara, et al.
Pageof 407